Clinical trials recruiting for Platinum-resistant Ovarian Cancer (PROC)
Fewer than 3 recruiting trials found.
2
Recruiting trials
21
US states with sites
4
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Bevacizumab | 2 |
| Pembrolizumab | 2 |
| Carboplatin | 1 |
| Doxorubicin | 1 |
| Eribulin | 1 |
| GI-102 | 1 |
| GI-102 subcutaneous (SC) | 1 |
| Paclitaxel | 1 |
| Rina-S | 1 |
| trastuzumab deruxtecan (T-DXd) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 2 |
| Florida | 2 |
| Minnesota | 2 |
| Ohio | 2 |
| California | 1 |
| Georgia | 1 |
| Kansas | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| New Jersey | 1 |
| New York | 1 |
Top cities
Abilene, Texas 1Augusta, Georgia 1Austin, Texas 1Boston, Massachusetts 1Camden, New Jersey 1Cleveland, Ohio 1Columbus, Ohio 1Dallas, Texas 1Detroit, Michigan 1Doylestown, Pennsylvania 1
Self-screener
Recruiting trials
- A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Related conditions
Trials recruiting for Platinum-resistant Ovarian Cancer (PROC) often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Uterine Cancer 10Type 2 diabetes 891Triple-negative breast cancer 138Soft Tissue Sarcoma (STS) 4Renal Cell Carcinoma (RCC) 10Primary Peritoneal Carcinoma 3Non-small cell lung cancer 507Metastatic Solid Tumor 22Mesothelioma 27
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Platinum-resistant Ovarian Cancer (PROC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.